The global Type 2 Diabetes market was valued at US$ 67000 million in 2022 and is projected to reach US$ 117640 million by 2029, at a CAGR of 8.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.
This report aims to provide a comprehensive presentation of the global market for Type 2 Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 2 Diabetes. This report contains market size and forecasts of Type 2 Diabetes in global, including the following market information:
- Global Type 2 Diabetes Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global Type 2 Diabetes Market Sales, 2018-2023, 2024-2032, (K Units)
- Global top five Type 2 Diabetes companies in 2022 (%)
The dramatic increase in the prevalence, progressive nature and diagnosis of type 2 diabetes is the main driver of this rapid growth rate. The rise in disease-related comorbidities has also fuelled a more aggressive approach to treatment, including the use of multiple-drug therapies.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Type 2 Diabetes manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Type 2 Diabetes Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Type 2 Diabetes Market Segment Percentages, by Type, 2022 (%)
- Insulins
- DPP-4 Inhibitors
- GLP-1 Receptor Agonists
- SGLT-2 Inhibitors
Global Type 2 Diabetes Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Type 2 Diabetes Market Segment Percentages, by Application, 2022 (%)
- Drugstore
- Hospital
- Others
Global Type 2 Diabetes Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Type 2 Diabetes Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Type 2 Diabetes revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Type 2 Diabetes revenues share in global market, 2022 (%)
- Key companies Type 2 Diabetes sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Type 2 Diabetes sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novo Nordisk
- Sanofi
- Merck
- Eli Lily
- AstraZeneca
- Astellas Pharma
- Daiichi Sankyo
- Biocon
- Boehringer Ingelheim
Outline of Major Chapters:
Chapter 1: Introduces the definition of Type 2 Diabetes, market overview.
Chapter 2: Global Type 2 Diabetes market size in revenue and volume.
Chapter 3: Detailed analysis of Type 2 Diabetes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Type 2 Diabetes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Type 2 Diabetes capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
